Real Event 201

The Real Event 201 was in 2018 in Hong Kong (v2)Housatonic Episode #960 (ep-d2024-0719-01-2)🟥Live2 / BitChute / Odysee / Rumble / Stream.GigaOhm.Bio

[Oct 14 2018] Li-Meng Yan "Combo live-attenuated inactivated influenza vaccines" Hong Kong pandemicHousatonicITS asset ID of MP4: HV01AGLive3 / BitChute / Odysee / Rumble / Stream.GigaOhm.Bio

[Oct 14 2018] Kizzmekia Corbett "Coronavirus vaccines, advancing towards general solution" Hong KongHousatonicITS asset ID of MP4: HV01AKLive3 / BitChute / Odysee / Rumble / Stream.GigaOhm.Bio

Framing Response to Next Pandemic (Oct 2018, Hong Kong symposium) Panel (Koopmans) Real Event 201HousatonicITS asset ID of MP4: HV01AO BitChute / Odysee / Rumble / Stream.GigaOhm.Bio

https://virtual.keystonesymposia.org/live/171/page/921

www.keystonesymposia.org/18S2

DELETED

pre-conference

https://web.archive.org/web/20180809004835/keystonesymposia.org/18S2

deleted by 2021

https://web.archive.org/web/20210211072250/https://www.keystonesymposia.org/18S2

Backup as o Feb 2021

2021-02-web-archive-org-www-keystonesymposia-org-18s2-20210211072250.jpg

CONFERENCE AGENDA, AS OF AUGUST 9 2019

https://web.archive.org/web/20180809004835/http://www.keystonesymposia.org:80/18S2

August 2018 ...

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835.pdf

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-01.jpg

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-02-monday

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-03-tuesday

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-04-wed

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-05-thur

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-img-06-friday-special-thanks.jpg

also

https://web.archive.org/web/20180724082434/http://www.keystonesymposia.org/index.cfm?e=Web.Meeting.Flyer&MeetingID=1557

2018-08-09-web-archive-org-www-keystonesymposia-org-18s2-20180809004835-meeting-flyer.pdf

Framing the Response to Emerging Virus Infections (S2)

Scientific Organizers: Ralph A. Tripp, Suresh Mahalingam, John W. Lowenthal, Andrew G. Bean and Malik Peiris

October 14—18, 2018

Lee Shau Kee Lecture Centre, Centennial Campus, The University of Hong Kong, Pok Fu Lam, Hong Kong

Organized in collaboration with the Croucher Foundation and The University of Hong Kong

IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.

BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:

*All deadlines end at 11:59 PM US Mountain Standard Time

Travel Award Deadline: Jun 27, 2018 [details]

Scholarship Deadline: Jun 27, 2018 [details]

Discounted Abstract Deadline: Jun 27, 2018 [details]

Abstract Deadline: Jul 17, 2018 [details]

Discounted Registration Deadline: Aug 14, 2018 [details]

Click here to view Cancellation Policy

No registration fees are used to fund entertainment or alcohol at this conference

Conference Program Print | View meeting in 12 hr (am/pm) time

The meeting will begin on Sunday, October 14 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, October 18 with a closing plenary session from 13:30 to 17:30, followed by a social hour. We recommend return travel on Friday, October 19 in order to fully experience the meeting.

SUNDAY, OCTOBER 14

16:00—20:00

Arrival and Registration

Hotel Jen Lobby

18:00—20:00

Welcome Mixer

No registration fees are used to fund alcohol served at this function.

Hotel Jen Lobby

MONDAY, OCTOBER 15

08:00—09:00

Poster Setup

Lecture Hall LG 2

09:00—17:30

Poster Viewing

Lecture Hall LG 2

09:00—10:00

Welcome and Keynote Address

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Malik Peiris, University of Hong Kong, Hong Kong

Gabriel M. Leung, Dean of Medicine, University of Hong Kong, Hong Kong

Opening Remarks

Peter Daszak, EcoHealth Alliance, USA

Emerging Infectious Disease Emergence

10:00—12:30

Mosquito Borne Viruses - Biology and Host Interactions

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Lisa E. Gralinski, University of North Carolina, USA

Scott C. Weaver, University of Texas Medical Branch, USA

Urban Arboviruses: History, Evolution and Mechanisms of Emergence

Coffee Break

Suresh Mahalingam, Griffith University, Australia

Alphavirus Inflammatory Disease Mechanisms and Approaches to Therapy

Michael S. Diamond, Washington University School of Medicine, USA

Host Factors Required for Alphavirus Infection: The Identification of Mxra8 as an Entry Receptor

Ali Zaid†, Griffith University Gold Coast, Australia

Short Talk: Specific Inhibition of NLRP3 in Chikungunya Disease Reveals a Role for Inflammasome in Alphavirus-Induced Inflammation

Kar Muthumani, Wistar Institute, USA

Short Talk: Synthetic Nucleic Acid Antibody Prophylaxis + DNA Vaccine Confers Rapid and Durable Protective Immunity against Zika Virus

12:30—13:30

Networking Lunch

Lecture Hall LG 2

13:00—15:00

Poster Session 1

Lecture Hall LG 2

15:00—15:30

Coffee Available

Lecture Hall LG 2

15:30—17:30

ZIKA Virus Countermeasures

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Suresh Mahalingam, Griffith University, Australia

Raman Rao, Takeda Pharmaceutical Company, USA

Talk Title to be Announced

Mauro Martins Teixeira, Universidade Federal de Minas Gerais, Brazil

The Role of Glutamate Receptors in the Pathogenesis of Zika

Speaker to be Announced

Natalie A. Prow, University of South Australia, Australia

Short Talk: A New Replication-Defective, Vaccinia-Derived, CHO-Manufactured, Vaccine Vector System (SCV) is Effective in Preclinical Studies against Zika and Chikungunya Viruses

Mingyuan Li, University of Hong Kong, Hong Kong

Short Talk: Activated ADP-Ribosylation Factor 4 (ARF4) is Required for ZIKA Virus (ZIKV) Infectious Cycle

TUESDAY, OCTOBER 16

08:30—09:00

Poster Setup

Lecture Hall LG 2

09:00—17:00

Poster Viewing

Lecture Hall LG 2

09:00—10:30

Ebola Virus: Biology and Host Interactions

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Erica Ollmann Saphire, The Scripps Research Institute, USA

Christopher F. Basler†, Georgia State University, USA

Talk Title to be Announced

Heinz Feldmann, Rocky Mountain Laboratories, USA

Animal Models of Ebolaviruses

Adam Joseph Hume†, Boston University, USA

Short Talk: The Use of Minigenome Systems as Tools to “Fill in the Blanks” for Uncultured Emerging Viruses and Facilitate Virus Rescue: A Lloviu Virus Case Study

Beatriz Escudero Pérez, Bernhard Nocht Institute for Tropical Medicine, Germany

Short Talk: Comparative Pathogenesis of Ebola and Reston Virus in Humanized Mice

Coffee Break

10:50—12:30

Ebola Virus: Vaccines and Therapeutics

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Heinz Feldmann, Rocky Mountain Laboratories, USA

Ana Maria Henao-Restrepo, World Health Organization, Switzerland

Talk Title to be Announced

Erica Ollmann Saphire, The Scripps Research Institute, USA

Structural Studies to Guide the Development of Broadly Reactive Antibodies against Ebolaviruses and Lassa Virus

John Misasi, NIH/NIAID/VRC, USA

Short Talk: ChAd3-Based Ebola Vaccination Induces Protective Antibody Classes

Sarah Elliott†, Wistar Institute, USA

Short Talk: A Synthetic Micro-consensus DNA Vaccine Induces Potent Immune Responses Against Diverse Strains of Marburgvirus

12:30—13:30

Lunch

Lecture Hall LG 2

13:00—15:00

Poster Session 2

Lecture Hall LG 2

14:30—15:00

Coffee Available

Lecture Hall LG 2

15:00—17:00

Zoonotic Influenza and MERS

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Andrew G. Bean, Commonwealth Scientific and Industrial Research Organization, Australia

Yi Guan, University of Hong Kong, Hong Kong

Zoonotic Influenza Viruses from China, a Persistent Pandemic Threat?

KY Yuen, University of Hong Kong, Hong Kong

Host Cellular Protein Facilitating Viral Replication

Bart L. Haagmans, Erasmus MC, Netherlands

MERS-Coronavirus: From Discovery to Intervention

Nicole Lai Giea Seng, University of Hong Kong, Hong Kong

Short Talk: Virulence Determinants of Novel Influenza A (H7N9) Virus in Mammals

Sabiha Jahan Akhee†, University of Hong Kong, Hong Kong

Short Talk: Deubiquitylase OTUB1 Plays Critical Role in Influenza A Virus Infection and Immune Response

WEDNESDAY, OCTOBER 17

09:00—12:30

MERS

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* John W. Lowenthal, Deakin University, Australia

Malik Peiris, University of Hong Kong, Hong Kong

Emerging Virus Disease at the Animal-Human Interface

Ralph S. Baric, University of North Carolina at Chapel Hill, USA

Rapid Response Strategies to Control Emerging Coronavirus Infections

Dong-Yan Jin†, University of Hong Kong, Hong Kong

Short Talk: Suppression of Type I Interferon Production by Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein through Interaction with HSP70 Chaperone

Lisa E. Gralinski, University of North Carolina, USA

Short Talk: Using a Reduced Complexity Cross to Identify Host Susceptibility Factors to SARS-CoV Infection

Coffee Break

* Bart L. Haagmans, Erasmus MC, Netherlands

John W. Lowenthal, Deakin University, Australia

A Strategy for Developing a MERS Camel Vaccine in order to Protect Humans

Jincun Zhao, Guangzhou Institute of Respiratory Disease, China

Immune Responses in MERS-CoV Infected Mice and Humans

Stalin Raj Victor, Indian Institute of Science Education and Research Thiruvananthapuram, India

Short Talk: Chimeric Camel-Human Heavy Chain Antibodies Protect Mice from MERS-CoV Infection

Neeltje van Doremalen, NIH/NIAID, USA

Short Talk: The Omics of Sex-Specific MERS-CoV Severity in a Transgenic Mouse Model

12:30—13:00

Poster Setup

Lecture Hall LG 2

12:30—17:00

On Own for Lunch and Recreation

13:00—21:30

Poster Viewing

Lecture Hall LG 2

16:30—17:00

Coffee Available

Lecture Hall LG 2

17:00—19:00

Emerging Disease Detection and Surveillance

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Ana Maria Henao-Restrepo, World Health Organization, Switzerland

Marion P.G. Koopmans, Erasmus MC, Netherlands

Challenges and Opportunities in Emerging Disease Detection

Gavin J.D. Smith, Duke-NUS Graduate Medical School, Singapore

Surveillance for Risk Assessment and Prediction

Linfa Wang, Duke-NUS Medical School, Singapore

From SARS to SADS: EIDs Caused by Bat Coronaviruses

Anna Uehara, Duke-NUS Medical School, Singapore

Short Talk: Serologic Evidence of Bat Orthoreovirus in Singapore

Kenrie Pui Yan Hui, University of Hong Kong, Hong Kong

Short Talk: Tropism and Pathogenesis of the Highly Pathogenic Avian Influenza A/H7N9 virus in ex vivo and in vitro Cultures of the Human Respiratory Tract

19:00—20:00

Social Hour with Lite Bites

Lecture Hall LG 2

19:30—21:30

Poster Session 3

Lecture Hall LG 2

THURSDAY, OCTOBER 18

09:00—12:30

Influenza: Immunity and Vaccines

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Ralph A. Tripp, University of Georgia, USA

Leo Poon, University of Hong Kong, Hong Kong

Universal Influenza Vaccines for Pandemic Response

Andrew G. Bean, Commonwealth Scientific and Industrial Research Organization, Australia

Tailoring the Avian Host Immune Response for Enhanced Vaccine Production

Sophie A. Valkenburg†, University of Hong Kong, Hong Kong

Short Talk: ADCC Antibodies are a Protective Immune Correlate in a Household Model of Influenza Transmission

Li-meng Yan, University of Hong Kong, Hong Kong

Short Talk: Combined use of Live-Attenuated and Inactivated Influenza Vaccines to Enhance Heterosubtypic Protection

Coffee Break

* Linfa Wang, Duke-NUS Medical School, Singapore

Ted M. Ross, University of Georgia, USA

Broadly Protective Influenza Vaccines: Protection Against Mismatched Strains

Mario Barro, Sanofi Pasteur, USA

Talk Title to be Announced

Tomas Cihlar†, Gilead Sciences, USA

Short Talk: Broad Spectrum Antiviral Remdesivir for the Treatment of Emerging Viral Infections with High Outbreak Potential

12:30—13:30

Lunch

Lecture Hall LG 2

13:30—16:00

Vaccine and Therapeutic Strategies

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

* Marion P.G. Koopmans, Erasmus MC, Netherlands

Stephen Whitehead, NIAID, National Institutes of Health, USA

Evaluation of Live Attenuated Vaccines for Dengue and Zika Viruses (and their Challenge Models)

Ralph A. Tripp, University of Georgia, USA

Novel Strategies to Improve Vaccine Yield

Coffee Break

Adam Taylor, Griffith University, Australia

Short Talk: Novel Delivery of a Live-Attenuated Chikungunya Virus Vaccine Candidate

James Duehr, Icahn School of Medicine, USA

Short Talk: Characterization of Humoral Immunity Generated against Andes Virus GnGc

Renu Khasa, Translational Health Science and Technology Institute, India

Short Talk: RNA Interference Based Membrane Trafficking Screen Identifies Drug Targets for Japanese Encephalitis Virus

Danielle E. Anderson, Duke-NUS Medical School, Singapore

Short Talk: SEC61B is a Cellular Host Factor Required for Mumps Virus Replication in Humans and Bats

16:00—16:30

Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Registered attendees can view abstracts starting on 09/14/2018

Grand Hall

17:30—18:30

Social Hour with Lite Bites

FRIDAY, OCTOBER 19

Departure

*Session Chair †Invited, not yet responded.

Keystone Symposia thanks our Sponsors for generously supporting this meeting:

We gratefully acknowledge the generous grant for this conference provided by:

National Institutes of Health

National Institute of Allergy and Infectious Diseases (NIAID)

Grant No. 1 R13 AI140574-01

[NOTE - Grant info available at https://grantome.com/grant/NIH/R13-AI140574-01 ]

Funding for this conference was made possible (in part) by 1 R13 AI140574-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,

Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:

Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,

Phone:+1 970-262-2676

https://sci-hub.se/10.1016/S1473-3099(20)30232-2

https://www.researchgate.net/publication/339546614_Emergence_of_a_novel_human_coronavirus_threatening_human_health